Eder De Carvalho Pincinato

Campinas, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

CGE26-144: Impact of OPRM1 Genetic Variants on Adverse Reactions and Opioid Switching in Lung Cancer Patients.

CGE26-144: Impact of OPRM1 Genetic Variants on Adverse Reactions and Opioid Switching in Lung Cancer Patients.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 29, 2026

CGE26-138: GSTP1 Variants and Ancestry as Predictors of Hematological Adverse Drug Reactions to Paclitaxel-Carboplatin Chemotherapy in Ovarian Cancer Patients.

CGE26-138: GSTP1 Variants and Ancestry as Predictors of Hematological Adverse Drug Reactions to Paclitaxel-Carboplatin Chemotherapy in Ovarian Cancer Patients.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

CGE26-320: Influence of SLC Genes Variants and Patient Ancestry on Adverse Reactions Induced by Carboplatin and Paclitaxel in Patients With Lung Cancer.

CGE26-320: Influence of SLC Genes Variants and Patient Ancestry on Adverse Reactions Induced by Carboplatin and Paclitaxel in Patients With Lung Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

CGE26-138: GSTP1 Variants and Ancestry as Predictors of Hematological Adverse Drug Reactions to Paclitaxel-Carboplatin Chemotherapy in Ovarian Cancer Patients.

CGE26-138: GSTP1 Variants and Ancestry as Predictors of Hematological Adverse Drug Reactions to Paclitaxel-Carboplatin Chemotherapy in Ovarian Cancer Patients.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

CGE26-144: Impact of OPRM1 Genetic Variants on Adverse Reactions and Opioid Switching in Lung Cancer Patients.

CGE26-144: Impact of OPRM1 Genetic Variants on Adverse Reactions and Opioid Switching in Lung Cancer Patients.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

CGE26-320: Influence of SLC Genes Variants and Patient Ancestry on Adverse Reactions Induced by Carboplatin and Paclitaxel in Patients With Lung Cancer.

CGE26-320: Influence of SLC Genes Variants and Patient Ancestry on Adverse Reactions Induced by Carboplatin and Paclitaxel in Patients With Lung Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

Influence of SNVs on adverse reactions and survival in gefitinib-treated lung cancer patients from a preliminary study.

Influence of SNVs on adverse reactions and survival in gefitinib-treated lung cancer patients from a preliminary study.

Journal: Scientific reports

Published: April 23, 2025

Association of ABC Efflux Transporter Genetic Variants and Adverse Drug Reactions and Survival in Patients with Non-Small Lung Cancer.

Association of ABC Efflux Transporter Genetic Variants and Adverse Drug Reactions and Survival in Patients with Non-Small Lung Cancer.

Journal: Genes

Published: March 12, 2025

Data normalization of plasma miRNA profiling from patients with COVID-19.

Data normalization of plasma miRNA profiling from patients with COVID-19.

Journal: Scientific reports

Published: June 13, 2024

Increased expression of miR-320b in blood plasma of patients in response to SARS-CoV-2 infection.

Increased expression of miR-320b in blood plasma of patients in response to SARS-CoV-2 infection.

Journal: Scientific reports

Published: March 22, 2024

Single-nucleotide polymorphisms related to vitamin D metabolism and severity or mortality of COVID-19: A systematic review and meta-analysis.

Single-nucleotide polymorphisms related to vitamin D metabolism and severity or mortality of COVID-19: A systematic review and meta-analysis.

Journal: Gene

Published: October 04, 2023

Quality of Life of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving High-Dose Cisplatin Chemotherapy and Radiotherapy.

Quality of Life of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving High-Dose Cisplatin Chemotherapy and Radiotherapy.

Journal: Southern medical journal

Published: June 17, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026